Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$12.24 - $21.25 $1.4 Million - $2.43 Million
-114,428 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$16.69 - $26.05 $36,701 - $57,283
-2,199 Reduced 1.89%
114,428 $2.2 Million
Q2 2021

Aug 10, 2021

BUY
$18.15 - $27.75 $1.36 Million - $2.07 Million
74,685 Added 178.07%
116,627 $2.95 Million
Q1 2021

May 10, 2021

SELL
$20.71 - $51.02 $61,902 - $152,498
-2,989 Reduced 6.65%
41,942 $1.03 Million
Q4 2020

Feb 08, 2021

BUY
$21.84 - $44.0 $64,449 - $129,844
2,951 Added 7.03%
44,931 $1.65 Million
Q3 2020

Nov 06, 2020

BUY
$13.63 - $24.12 $225,072 - $398,293
16,513 Added 64.84%
41,980 $909,000
Q2 2020

Aug 05, 2020

BUY
$7.65 - $14.11 $61,031 - $112,569
7,978 Added 45.62%
25,467 $330,000
Q1 2020

May 12, 2020

BUY
$4.75 - $12.41 $256 - $670
54 Added 0.31%
17,489 $141,000
Q4 2019

Feb 05, 2020

BUY
$8.73 - $12.95 $152,207 - $225,783
17,435 New
17,435 $190,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $159M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.